The plain-language version
Okay, but what is it actually?
It is a once-weekly treatment that works through GIP and GLP-1 pathways. It may support appetite and fullness; a licensed clinician determines whether it is appropriate for you.
A more comprehensive approach
Tirzepatide is a clinician-guided weight-care option that works through both GIP and GLP-1 pathways involved in appetite and fullness.
Starting at $X/month

The plain-language version
It is a once-weekly treatment that works through GIP and GLP-1 pathways. It may support appetite and fullness; a licensed clinician determines whether it is appropriate for you.
The format
Clear format. Personal clinical review. No one-size-fits-all promises.
Why people choose it
Works across GIP and GLP-1 pathways as part of a more comprehensive treatment approach.
Designed to support the signals involved in appetite and fullness.
A weekly format that can fit more naturally into real life.
Everything included
It is a once-weekly treatment that works through GIP and GLP-1 pathways. It may support appetite and fullness; a licensed clinician determines whether it is appropriate for you.
A licensed clinician reviews your health information, goals, and relevant history before deciding whether treatment is medically appropriate.
Semaglutide works through one pathway. Tirzepatide works through two. Think of it as the more comprehensive option—not automatically the right option for everyone. That decision belongs to you and your clinician.
Safety depends on the treatment and your personal health history. Review the complete safety information and discuss questions with your clinician.